Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

PIP5K2A (rs10828317) polymorphism in patients with alcohol dependence and affective disorders

https://doi.org/10.14412/2074-2711-2021-3-48-52

Full Text:

Abstract

Alcohol dependence (AD) and affective disorders (ADs) are serious medical and socio-economic problems of modern society. It is hypothesized that both disorders share a common neurobiological basis. Phosphatidylinositol-4-phosphate-5-kinase type 2 alpha (PIP5K2A) plays an essential role in neuronal phosphoinositide signaling pathways. Nonsynonymous rs10828317 mutation of the PIP5K2A gene leads to conformational changes of the PIP5K2A protein and a decrease in the functional activity of this enzyme. In this study, we assessed the possibility of using the rs10828317 polymorphic variant of the PIP5K2A gene as a marker of AD and ADs.

Objective: to study the associations of the PIP5K2A (rs10828317) polymorphism with AD and ADs clinical course.

Patients and methods. We enrolled 255 patients with AD and 325 patients with ADs. 126 patients with AD and 71 patients with ADs underwent a comprehensive clinical, clinical-dynamic, psychodiagnostic assessment using a set of clinical scales and tests, including Structured Interview Guide For The Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD), Alcohol Use Disorders Identification Test (AUDIT), The Obsessive-Compulsive Drinking Scale for craving in alcohol (OCDS).

Results and discussion. PIP5K2A (rs10828317) polymorphism in patients with AD was associated with the OCDS mean score after the inpatient treatment; in patients with ADs - with the severity of atypical depression symptoms assessed by SIGH-SAD at the time of admission.

Conclusion. The results of our pilot study indicate the involvement of PIP5K2A (rs10828317) polymorphism in the AD and ADs pathophysiology.

About the Authors

E. V. Mikhalitskaya
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Ekaterina Viktorovna Mikhalitskaya

4, Aleutskaya Str., Tomsk 634014



N. M. Vyalova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

4, Aleutskaya Str., Tomsk 634014



O. Yu. Fedorenko
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk National Research Polytechnic University
Russian Federation

4, Aleutskaya Str., Tomsk 634014,

30, Lenina Ave., Tomsk 634050



O. V. Roshchina
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

4, Aleutskaya Str., Tomsk 634014



G. G. Simutkin
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

4, Aleutskaya Str., Tomsk 634014



N. A. Bokhan
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

4, Aleutskaya Str., Tomsk 634014



S. A. Ivanova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk National Research Polytechnic University
Russian Federation

4, Aleutskaya Str., Tomsk 634014,

30, Lenina Ave., Tomsk 634050



References

1. McHugh RK, Weiss RD. Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019 Jan 1;40(1):arcr.v40.1.01. doi: 10.35946/arcr.v40.1.01. eCollection 2019 Oct 21.

2. Korolenko TsP, Dmitrieva NV. Psihosotsialnaya addiktologiya [Psychosocial Addictology]. Novosibirsk: Olsib; 2001. 251 р. (In Russ.).

3. Kessler RC, Chiu WT, Demler O. Prevalence, severity, and comorbidity of 12- month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617

4. Gomez-Coronado N, Sethi R, Bortolasci CC. A review of the neurobiological underpinning of comorbid substance use and mood disorders. J Affect Disord. 2018 Dec 1;241:388-401. doi: 10.1016/j.jad.2018.08.041. Epub 2018 Aug 11.

5. Jang SK, Saunders G, Liu M, et al. Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder. Psychol Med. 2020 Aug 7;1-11. doi: 10.1017/S003329172000272X. Online ahead of print.

6. Fedorenko OYu, Ivanova SA, Bokhan NA. Geneticheskiye narusheniya proteinkinaz pri psikhicheskikh rasstroystvakh na modeli PIP5K2A, SGK1 i GSK-3β [Genetic disorders of protein kinases in mental disorders in the PIP5K2A, SGK1 and GSK-3β model]. Saarbrücken: Palmarium Academic Publishing; 2013. 85 p. (In Russ.).

7. Koch M, Holt M. Coupling exoand endocytosis: an essential role for PIP2 at the synapse. Biochim Biophys Acta. 2012 Aug;1821(8):1114-32. doi: 10.1016/j.bbalip.2012.02.008. Epub 2012 Feb 23.

8. Suh BC, Hille B. PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys. 2008;37:175-95. doi: 10.1146/annurev.biophys.37.032807.125859

9. Fedorenko O, Strutz-Seebohm N, Henrion U. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology (Berl). 2008 Jul;199(1):47-54. doi: 10.1007/s00213-008-1095-x. Epub 2008 Jun 11.

10. Fedorenko OYu, Loonen AJ, Lang F, et al. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia. International J Neuropsychopharmacol. 2014 Dec 28;18(6):pyu098. doi: 10.1093/ijnp/pyu098

11. Fedorenko O, Tang C, Sopjani M, et al. PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. Psychopharmacology (Berl). 2009 Oct;206(3):429-35. doi: 10.1007/s00213-009-1621-5. Epub 2009 Jul 31.

12. Seebohm G, Wrobel E, Pusch M, et al. Structural basis of PI(4,5)P2-dependent regulation of GluA1 by phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP5K2A). Pflugers Arch. 2014 Oct;466(10):1885-97. doi: 10.1007/s00424-013-1424-8. Epub 2014 Jan 5.

13. Jamra RA, Klein K, Villela AW, et al. Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):663- 5. doi: 10.1002/ajmg.b.30358

14. Saggers-Gray L, Heriani H, Handoko HY, et al. Association of PIP5K2A with schizophrenia: a study in an indonesian family sample. Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1310-3. doi: 10.1002/ajmg.b.30736

15. Stopkova P, Vevera J, Paclt I, et al. Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia. Psychiatr Genet. 2005 Sep;15(3):223-7. doi: 10.1097/00041444-200509000-00015

16. Carter CJ. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem Int. 2007 Feb;50(3):461-90. doi: 10.1016/j.neuint.2006.11.009. Epub 2007 Jan 18.

17. Vyalova NM, Pozhidaev IV, Osmanova DZ, et al. Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova. 2017;117(5):58-61. doi: 10.17116/jnevro20171175158-61 (In Russ.).

18. Vyalova NM, Osmanova DZ, Pozhidaev IV, et al. Role of PIP5K2A polymorphic variants in the pathogenesis of depressive disorders. Sovremennyye problemy nauki i obrazovaniya. 2015;(6):41 (In Russ.).

19. Vyalova NM, Fedorenko OYu, Losenkov IS. Study of the association of PIP5K2A gene polymorphisms with depressive disorders. Fundamental'nyye issledovaniya. 2013;(12- 1):107-10 (In Russ.).

20. Fedorenko OIu, Rudikov EV, Gavrilova VA, et al. Association of (N251S)-PIP5K2A with schizophrenic disorders: a study of the Russian population of Siberia. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2013;13(5):58-61 (In Russ.).


For citation:


Mikhalitskaya E.V., Vyalova N.M., Fedorenko O.Yu., Roshchina O.V., Simutkin G.G., Bokhan N.A., Ivanova S.A. PIP5K2A (rs10828317) polymorphism in patients with alcohol dependence and affective disorders. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):48-52. https://doi.org/10.14412/2074-2711-2021-3-48-52

Views: 95


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)